The pro-crossing function of Abl relies partly on its kinase activity. (A,B) Quantification of EW axon crossing defects in Abl mutants. (A) frahypo embryos. Expression of kinase-inactive Abl (AblKN) in EW neurons rescues the dominant interaction between fra and Abl. Data from two independent transgenic UAS-AblKN lines are shown. (B) Embryos expressing a weak DN-Fra transgene, which causes no defects in WT embryos (data not shown). AblWTGFP rescues midline-crossing defects in Abl2 homozygous mutants, though AblKNGFP does not. *P<0.05, **P<0.01, ***P<0.001. n.s., not significant. Error bars indicate s.e.m. Number of segments scored is shown in parentheses. Genotypes are as follows: (A) frahypo denotes fra3,[UAS-TauMycGFP]/fra6; [eg-Gal4]/+; Abl4/+ denotes fra3,[UAS-TauMycGFP]/fra6; Abl4,[eg-Gal4]/+; these two are a repetition of data shown in Fig. 1. +AblKN denotes fra3,[UAS-TauMycGFP]/fra6, [UAS-AblKN]2; Abl4,[eg-Gal4]/+; and +AblKNGFP denotes fra3,[UAS-TauMycGFP]/fra6; Abl4,[eg-Gal4]/[UAS-AblKNGFP]. (B) abl2/+ denotes [UAS-DN-Fra]#8/[UAS-TauMycGFP]; Abl2, [eg-Gal4] / +. On the right, all are [UAS-DN-Fra]#8/[UAS-TauMycGFP]; Abl2, [eg-Gal4]/Abl2, [UAS-AblXGFP].